EPIDEMIOLOGY OF UROLITHIASIS IN THE TURKESTAN REGION
Background: Urolithiasis is one of the most common urological diseases worldwide and in Kazakhstan after renal inflammatory diseases. Aim: to study the epidemiology of diseases of the urinary system with a particular interest in urolithiasis. Methods: The prevalence of diseases of the organs of the urinary system was observed in 81327 examined individuals, who were hospitalized in the clinics of the Turkestan region. Among urological diseases were chronic tubulointerstitial nephritis, chronic obstructive and non-obstructive pyelonephritis, terminal stages of kidney damage, tubulointerstitial kidney damage, renal cysts, acute tubulointerstitial nephritis, urinary tract infections, chronic nephritic disorders cystitis, hydronephrosis and others. Statistical analyses were carried out using MATLAB application package version R2017b (MathWorks, USA) and plots were drawn using Microsoft Excel. Results: The incidence of pathologies of organs of the urinary system has increased by 1.17 times both from 2017 to 2018 and from 2018 to 2019 with linear growth (R2 = 9964). Kidney stones with a prevalence of 1.4% among the pathology of the system are in 7th place. Results of the study indicate that more than 500 people will require hospitalizations in the coming years due to the stagnation of clinical administration due to the onset of COVID-19 pandemics in the end of the observation period. Conclusion: There has been noted that the prevalence of kidney stone disease is among the leading cause of hospitalisation in the Turkestan region and the incidence rate is steadily increasing. Key words: urolithiasis, epidemiology, Turkestan region.
Reza A. Fatkhi1, https://orcid.org/0000-0001-5372-3155 Shora M. Seidinov1, https://orcid.org/0000-0002-4236-3526 1 Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan, Republic of Kazakhstan
1. Lopatkin N.A., Dzeranov N.K. Pyatnadtsatiletnii opyt primeneniya DLT v lechenii MKB [Fifteen years of experience in the use of DLT in the treatment of ICD]. Mater. Plenuma Pravleniya Ros.obshchestva urologov [Mater. Plenum of the Board of the Russian Society of Urologists]. Sochi-Moskva. 2003. pp. 5-25. [in Russian]. 2. Akoudad S., Szklo M., McAdams M.A., Fulop T., Anderson C.A., Coresh J., Köttgen A. Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study // Preventive medicine. 2010. N 51(5). P. 416-420. 3. Asper R. Epidemiology and socioeconomic aspects of urolithiasis // Urological Research. 1984. N 12(1). P. 1-5. 4. Baatiah N.Y., Alhazmi R.B., Albathi F.A., Albogami E.G., Mohammedkhalil A.K., Alsaywid B.S. Urolithiasis: Prevalence, risk factors, and public awareness regarding dietary and lifestyle habits in Jeddah, Saudi Arabia in 2017 // Urology annals. 2020. N 12(1). P. 57-62. 5. Bartoletti R., Cai T., Mondaini N., Melone F., Travaglini F., Carini M. Epidemiology and risk factors in urolithiasis // Urology International. 2007. N 79. P. 3-7. 6. Bichler K.H., Eipper E., Naber K., Braun V., Zimmermann R., Urinary infection stones // International Journal of Antimicrobe Agents. 2002. N 19(6). P. 488-98. 7. Chand R.B., Shah A.K., Pant D.K., Paudel S. Common site of urinary calculi in kidney, ureter and bladder region // Nepal Medical Collection Journal. 2013. N 15(1). P. 5-7. 8. Copelovitch L. Urolithiasis in children: medical approach // Pediatric clinics of North America. 2012. N 59(4). P. 881-896. 9. Daudon M., Bounxouei B., Santa Cruz F., Leite da Silva S., Diouf B., Angwafoo F.F. 3rd, Talati J., Desrez G. Composition des calculs observés aujourd'hui dans les pays non industrialisés [Composition of renal stones currently observed in non-industrialized countries] // Progrès en Urologie. 2004. N 14(6). P. 1151-61. 10. Freitas Junior C.H., Mazzucchi E., Danilovic A., Brito A.H., Srougi M. Metabolic assessment of elderly men with urolithiasis // Clinics. 2012. N 67. P. 457-461. 11. García-Perdomo H.A., Solarte P.B., España P.P. Pathophysiology associated with forming urinary stones // Urología Colombiana. 2016. N 25(2). P. 118-125. 12. López M., Hoppe B. History, epidemiology and regional diversities of urolithiasis // Pediatric Nephrology. 2010. N 25(1). P. 49-59. 13. Michell A.R. Urolithiasis-historical, comparative and pathophysiological aspects: a review // Journal of the Royal Society of Medicine. 1989. N 82(11). P. 669-672. 14. Milliner D.S., Murphy M.E. Urolithiasis in pediatric patients // Mayo Clinic Proceedings. 1993. N 68(3). P. 241-8. 15. Morgan M.S.C., Pearle M.S. Medical management of renal stones // BMJ. 2016. N 352. P. 52. 16. Kokorowski P.J., Hubert K., Nelson C.P. Evaluation of pediatric nephrolithiasis // Indian journal of urology. 2010. N 26(4). P. 531-5. 17. Pyrah L.N. Epidemiology of Urolithiasis, in Renal Calculus, L.N. Pyrah, Editor. 1979. Springer Berlin Heidelberg: Berlin, Heidelberg. P. 3-17. 18. Ramello A., Vitale C., Marangella M. Epidemiology of nephrolithiasis // Journal of Nephrology. 2000. N 13. P. 45-50. 19. Rizvi S.A., Naqvi S.A., Hussain Z., Hashmi A., Hussain M., Zafar M.N., Sultan S., Mehdi H. Pediatric urolithiasis: developing nation perspectives // Journal of Urology. 2002. N 168(4 Pt 1). P. 1522-5. 20. Robertson W.G., Hughes H. Epidemiology of Urinary Stone Disease in Saudi Arabia, in Urolithiasis 2, R. Ryall, et al., Editors. 1994, Springer US: Boston, MA. P. 453-455. 21. Sas D.J., Hulsey T.C., Shatat I.F., Orak J.K. Increasing incidence of kidney stones in children evaluated in the emergency department // Journal of Pediatrics. 2010. N 157(1). P. 132-137. 22. Singh V.K., Rai P.K. Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review // Biophysical reviews. 2014. N 6(3-4). P. 291-310. 23. Stitchantrakul W., Kochakarn W., Ruangraksa C., Domrongkitchaiporn S. Urinary risk factors for recurrent calcium stone formation in Thai stone formers // Journal of Medical Association of Thailand. 2007. N 90(4). P. 688-98. 24. Strope S.A., Wolf J.S., Hollenbeck B.K. Changes in gender distribution of urinary stone disease // Urology. 2010. N 75(3). P. 543-546. 25. Tekin A., Tekgul S., Atsu N., Sahin A., Ozen H., Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor // Journal of Urology. 2000. N 164(1). P. 162-5. 26. Touhami M., Laroubi A., Elhabazi K., Loubna F., Zrara I., Eljahiri Y., Oussama A., Grases F., Chait A. Lemon juice has protective activity in a rat urolithiasis model // BMC urology. 2007. N 7. P. 18-18. 27. Trinchieri A. Epidemiology of urolithiasis // Archives of Italian Urology and Andrology. 1996. N 68(4). P. 203-49. 28. Trinchieri A. Epidemiology of urolithiasis: an update // Clinical cases in mineral and bone metabolism: the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases. 2008. N 5(2). P. 101-106. 29. Turk C. EAU guidelines on urolithiasis. 2011. 30. VanDervoort K., Wiesen J., Frank R., Vento S., Crosby V., Chandra M., Trachtman H. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome // Journal of Urology. 2007. N 177(6). P. 2300-5.
Количество просмотров: 399

Ключевые слова:


Библиографическая ссылка

Fatkhi R.A., Seidinov Sh.M. Epidemiology of urolithiasis in the Turkestan region // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 3, pp. 139-145. doi 10.34689/SH.2021.23.3.016 Фатхи Р.А., Сейдинов Ш.М. Эпидемиология мочекаменной болезни в Туркестанской области // Наука и Здравоохранение. 2021. 3(Т.23). С. 139-145. doi 10.34689/SH.2021.23.3.016 Фатхи Р.А., Сейдинов Ш.М. Түркістан облысы бойынша несеп-тас ауруының эпидемиологиясы // Ғылым және Денсаулық сақтау. 2021. 3 (Т.23). Б. 139-145. doi 10.34689/SH.2021.23.3.016

Авторизируйтесь для отправки комментариев